 protect effect beta agonist excess airway respons stimuli asthma chronic obstruct lung diseas beta agonist hypersensit stimuli patient asthma chronic obstruct lung diseas drug excess airway narrow effect inhal salbutamol posit shape dose-respons curv histamin methacholin patient asthma chronic obstruct lung diseas pretreat salbutamol microgram placebo doubl blind manner dose-respons curv inhal histamin methacholin standard method day random order airway sensit concentr histamin methacholin fall maxim respons plateau log dose-respons curv present data point respons rang absenc plateau test predetermin level sever bronchoconstrict salbutamol acut increas mean increas asthma chronic obstruct lung diseas mean fold asthma chronic obstruct lung diseas increas slope dose-respons curv group subject plateau respons level plateau subject plateau salbutamol develop plateau median asthma chronic obstruct lung diseas result beta agonist airway respons strength bronchoconstrictor stimulu excess airflow obstruct exposur strong stimuli steepen dose-respons curv disadvantag beta agonist treatment moder sever asthma chronic obstruct lung diseas